SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : DLB Dolby Laboratories
DLB 80.75+1.8%Aug 12 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Cooters7/30/2021 12:01:04 PM
   of 282
 
CFRA MAINTAINS HOLD OPINION ON SHARES OF DOLBY LABORATORIES, INC.

3:03 pm ET July 30, 2021

Our 12-month target of $100 (up by $4), 25.6x our FY 22 (Sep.) EPS estimate, is aligned with the DLB's five-year historical trading band. We increase our FY 21 EPS estimate to $3.62 from $3.45 and FY 22's EPS to $3.91 from $3.84. DLB prints Jun-Q adj-EPS of $0.71 vs. $0.86, compared to consensus of $0.48, as sales growth and expense controls led to operating margin upside (26% vs. 24% expected). Revenues were $287M (up 16.7% Y/Y), topping consensus by $8M, as a shipment true-up of $14M drove the beat in its entirety. Total licensing revenue rose nicely by 15.5%, as higher recoveries in broadcast more than offset declines in mobile. DLB maintained its assumptions that PC markets likely remain the key growth driver for the remainder of FY 21, which led to the company to modestly raise the low-end of its second half revenue target to $570M (from $560M). The quarter was sound, with no glaring outliers, but a lack of near-term catalysts likely keeps shares in a tight trading range in the interim, in our opinion.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext